Gangliosides Block a Toxin from an Oral Pathogen
Author Information
Author(s): Michael S. Forman, Jason B. Nishikubo, Rebecca K. Han, Amy Le, Nataliya V. Balashova, Scott C. Kachlany
Primary Institution: Department of Oral Biology, New Jersey Dental School, University of Medicine and Dentistry of New Jersey
Hypothesis
Can gangliosides block the hemolytic activity of leukotoxin from Aggregatibacter actinomycetemcomitans?
Conclusion
Gangliosides can effectively block the hemolysis caused by leukotoxin from Aggregatibacter actinomycetemcomitans.
Supporting Evidence
- LtxA can lyse red blood cells and gangliosides can block this effect.
- LtxA does not recognize glycophorin on red blood cells.
- Gangliosides were only partially effective at preventing LtxA-mediated cytotoxicity of white blood cells.
Takeaway
This study found that certain fats and sugars called gangliosides can stop a harmful toxin from killing red blood cells.
Methodology
The study involved testing the ability of gangliosides to block LtxA-mediated hemolysis using various cell lines and flow cytometry.
Limitations
Gangliosides were only partially effective at blocking LtxA-mediated cytotoxicity of white blood cells.
Participant Demographics
The study involved human blood from healthy volunteers.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website